Grupo IMO of Madrid Hosts International Symposium on TomoTherapy® Radiation Treatments
Fundación Grupo IMO—the scientific and non-profit branch of the Oncology Institute of Madrid—recently hosted an international symposium on “New Horizons in Cancer Treatment: TomoTherapy.” Sponsored by the Ramón Areces Foundation, the two-day symposium was held on November 23 – 24, 2006, and brought together experts from across the US and Europe to discuss technical and clinical experiences with the TomoTherapy® Hi·Art System®, as well as new and recent developments in image guidance, stereotactic body radiotherapy, and adaptive radiotherapy.
From left to right: Dr. Vincent Grégoire, Dr. Rosa Morera, Dr. José Samblás, and (foreground) Dr. Gustavo Olivera.
The symposium opened with presentations by Mr. Federico Mayor Zaragoza, President of the Scientific Board of Fundación Ramón Areces and former Director-General of UNESCO; José María Segovia de Arana, Scientific Advisor for the Fundación Ramón Areces; José Samblás, President of Grupo IMO and symposium Coordinator; and Ana Mañas, President of the Sociedad Española de Oncología Radioterápica (SEOR). In addition, Dr. Gustavo Olivera, Vice President of Research at TomoTherapy Inc. and Adjunct Associate Professor at the University of Wisconsin-Madison, presented on “TomoTherapy: Technical aspects and work in progress.” Other distinguished presenters and moderators included:
Dr. Paul Read
University of Virginia, Charlottesville
Dr. Lane Rosen
Willis-Knighton Cancer Center, Shreveport
Dr. Guy Storme
AZ-VUB, Brussels
Dr. Julio R. Villanueva
Fundación Ramón Areces
Dr. Katja Langen
M. D. Anderson Cancer Center - Orlando
Dr. Minesh Mehta
University of Wisconsin, Madison
Dr. Rosa Morera
Clínica La Milagrosa, Madrid
Dr. Nadia di Muzio
Hospital San Raffaele, Milán
Dr. Brian Butler
Methodist Hospital, Houston
Dr. Felipe Calvo
Hospital General Universitario Gregorio Marañón, Madrid
Dr. José Miguel Delgado
Grupo IMO, Madrid
Dr. José María Delgado
Grupo IMO, Madrid
Dr. Vincent Grégoire
St-Luc University Hospital
Dr. Manuel de las Heras
Hospital Clínico Universitario San Carlos, Madrid
Dr. Klaus Herfarth
University Clinic, Heidelberg
Dr. Carlos Pérez
Siteman Cancer Center, Washington University, St. Louis
Dr. Chester Ramsey
Thompson Cancer Survival Center, Knoxville
Said Dr. Samblás, “It was a pleasure to be able to bring together such a broad group of experts with the aim of sharing the knowledge and advances achieved by each one in their environment, and which stem from a common idea: to attain more efficacious treatments against cancer.”
Grupo IMO is the first facility in Spain to offer TomoTherapy® radiation treatments, treating patients on the Hi·Art System® since April 2006. Established in 1991, Grupo IMO has the largest autonomous network of seven reference centers for cancer treatment using radiotherapy and radiosurgery techniques in Spain.
6 Dec 2006
